CARBOPLATIN
NDC 82511-004, CARBOPLATIN, injection, solution, from Teyro Labs Private Limited.
- Product NDC
- 82511-004
- Status
- Listed
- Labeler
- Teyro Labs Private Limited
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077861
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82511-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBOPLATIN150 mg/15mL
Pharmacologic classes
Platinum-based Drug [EPC]; Platinum-containing Compounds [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82511-004-15 | 82511000415 | 1 VIAL, MULTI-DOSE in 1 CARTON (82511-004-15) / 15 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f64a0cbe-7fe3-407e-8933-21c30e1a1ebc
Use it
Look up 82511-004 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82511-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82511-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.